PES2020-Prosj.etabl.støtte H2020
A clinical phase I/II trial for the vaccine Vacc-C5 in HIV patients.
Bionor currently has two vaccines in clinical development (Vacc-4x and Vacc-C5) for functional HIV cure; i.e. leading to long-term remission of HIV infection in the absence of antiretroviral therapy (ART), the state-of-the art treatment for HIV today. A functional cure will provide a new paradigm...
